ROCHESTER, N.Y., May 26, 2026—CooperVision will share several scientific studies that advance multiple aspects of contact lens clinical practice during BCLA Asia 2026, including new insights into myopia management, astigmatic fitting, and presbyopia. This year’s conference takes place from May 29-31, 2026, in Tokyo, Japan, in partnership with the Japan Contact Lens Society (JCLS).
“CooperVision’s contact lens leadership is built on purpose-driven innovation and novel methods to elevate care, supported by studies like those we are presenting in Tokyo,” said Karen Walsh, MCOptom, PGDip, FAAO, FIACLE, FBCLA, the company’s Senior Director, Global Professional Affairs. “Eye care professionals (ECPs) can immediately apply many of our findings within their practices, from children to older adults.”
Behaviour Change Insights: Leveraging the Transtheoretical Model to Guide Education in Myopia Management (Huang J, T Song)1 explores how parent information needs vary during their children’s myopia management journey, helping ECPs better address distinct motivations and obstacles throughout the process. Researchers mapped more than 500 parent-related statements to five stages of care: pre-contemplation, contemplation, preparation, action, and maintenance. Subsequently, they showed how the transtheoretical model can guide stage‑matched, evidence‑based communication to improve parental understanding, support informed decision making, and increase myopia management adoption and adherence.
The company will also present Japan-specific physiological and wearer experience clinical study data related to its recent introduction of MiSight® 1 day myopia control contact lens in the country. In addition, it is offering the five-session CooperVision Myopia Management Symposium during the conference, featuring multiple international academic and clinical experts.
Another research highlight is Effect of Toric Power Alterations on Soft Toric Lens Fit and Rotation (Dutta D, et al),2 which acknowledges potential obstacles of practices having exact toric contact lens parameters in their fit set with increased ranges. The prospective, randomized, cross-over, open-label, controlled study (n=19) determined there was no significant difference in fitting patterns, particularly in the axis orientation, for toric daily disposable contact lenses of the same material and specifications when varying the toric power by ±1.00DC. This work, expanding on a related investigation presented at the 2026 Netherlands Contact Lens Congress (NCC), may help ECPs save chair time by reducing additional fittings prior to dispensing/ordering the exact prescription with astigmatic patients.3 The study was conducted with the Optometry and Vision Science Research Group at Aston University.
In keeping with ongoing initiatives to help ECPs provide optimal care for presbyopes, CooperVision scientists will share findings from various multifocal contact lens studies, including pupil size considerations and the earlier implementation of presbyopia management in Japan.4
BCLA Asia 2026 and the concurrent 68th Annual Meeting of the Japan Contact Lens Society are expected to attract upwards of 3,000 eye care professionals, educators, and researchers from across Japan, the Asia-Pacific region, and globe to the Takanawa Gateway Convention Center. CooperVision, a conference platinum sponsor, will present its complete portfolio of contact lenses as part of the corresponding exhibition.
1. Huang JC, Song T. Behaviour change insights: leveraging the transtheoretical model to guide education in myopia management. BCLA Asia 2026 Abstracts.
2. Dutta D, Coates A, Olner C, Dhanabalan C, Sulley A. Effect of toric power alterations on soft toric lens fit and rotation. BCLA Asia 2026 Abstract.
3. NCC. NCC ‘GET CONNECTED 2026’ paper abstracts (BCLA scientific stream). NCC 2026 abstract. Available from: https://www.contactlenscongress.com/mijnncc/uploads/abstracts/28_2026.pdf.
4. Sulley A, Marullo R, Guillon M, Lazon de la Jara P. Does pupil size need to be considered when fitting a multifocal contact lens for optimal vision performance? BCLA Asia 2026 abstract.
SA17964/APP163990
# # #
About CooperVision
CooperVision, a division of CooperCompanies (Nasdaq:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric, and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Media Contact
Mike McDougall, FAAO, APR, Fellow PRSA
McDougall Communications for CooperVision
mike@mcdougallpr.com or +1.585.434.2150